1 / 23

Staphylococcus epidermidis:

glora
Télécharger la présentation

Staphylococcus epidermidis:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Staphylococcus epidermidis: Dr. Michelle Alfa Ph.D, FCCM Diagnostic Services of Manitoba St. Boniface General Hospital Site

    2. Will the REAL S.epidermidis please stand up??

    3. Overview: Characteristics of Staphylococcus - Diseases Caused by S.epidermidis - Virulence Factors: Host infection In vivo versus environmental factors - invasive disease - biofilm formation on indwelling devices Unique virulence factors Prevention of infection

    4. Gram positive cocci in clusters - Catalase (+) Genus Staphylococcus has 37 species human infections: S.aureus, S.epidermidis, S.lugdenensis, S.saprophyticus Skin (axilla, head, nares) main reservoir (103 cfu/cm2) - S.aureus colonizes ~20% of people - S.epidermidis colonizes ~100% of people Classified by coagulase (+) vs (-) Multi-resistant to antibiotics Staphylococcus species: Characteristics

    5. S.epidermidis - Human infections

    7. Pathogenesis: Exposure: - Skin: reservoir - Trauma: e.g. surgery, line etc Localization: Biofilm: - adherance to catheter, implant - replication? biofilm formation; Dissemination/Damage: - shedding from biofilm - septicemia, inflammation

    8. Protective exopolymers:(aka; slime!) PNAG (poly-N-acetylglucosamine); protects form IgG, AMPs, phagocytosis and complement; synthesized from ica operon - 85% of device-related strains had gene vs 6% sapro strains (McCann et al 2008) (PGA(poly-gama-glutamic acid); protects from AMPs (anti-microbial peptides found on skin), & phagocytosis Toxins: PSMs: pro-inflammatory cytolysins (not strong) Staphyloferrins: siderophore iron acquisition Virulence Factors: S.epidermidis

    9. S.epidermidis Cell surface: Proteins & Polysaccharide

    10. Quorum Sensing: regulates biofilm formation - agr (accessory gene regulator); - luxS (AI-2; intraspecies communication); affects PNAG production (Note: this system found in many orgs) MSCRAMMs: (microbial surface components recognizing adhesive matrix molecules) Initial attachment phase - surface proteins on S.epidermidis (SdrF, SdrG etc) that bind to host matrix: collagen, fibronectin, fibrinogen, vitronectin Aggregation/biofilm maturation: - Surface proteins; Bap(biofilm associated protein) & Aap (accumulation associated protein) - Exopolymer PNAG (also called PIA); intercellular adhesion Virulence Factors: S.epidermidis

    11. Quorum Sensing Systems: agr and LuxS

    12. S.epidermidis surface protein SdrF binds collagen

    13. Biofilm: S.epidermidis

    14. S. epidermidis: Biofilm protection from Host defenses Enters “non-aggressive” state reduced inflammation & chemotaxis of immune cells

    15. S.epidermidis Biofilm Composition:Polysaccharide & Protein (stronger than protein alone) Quorum sensing: “…organisms in the biofilm as a whole behave as a multicellular organism, able to resist treatment which would kill isolated cells.” (D. Mack et al 2007)

    16. Antibiotic Treatment Stimulators of biofilm? - Subinhibitory conc of Vanco stimulates biofilm (Cargill & Upton 2009) Therapeutic efficacy? - McCann et al 2008 Resistance development? - transfer of genes

    17. S.epidermidis: Antibiotic Resistance

    18. Treatment: Infection of Indwelling device Antibiotics: choice limited, long duration Usually requires removal of device

    19. Treatment: Novel methods Agr pheromones are species specific: Use synthetic peptides from one org to treat another org e.g. RIP (heptapeptide): is an RNAIII-inhibiting peptide: useful adjunct with antibiotics to inhibit agr-activation in S.aureus & S.epidermidis (Mack et al 2007)

    20. Prevention: Vaccinate against: PNAG, techoic acid, protein adhesins of org Short hospital stays to lessen risk of acquiring pathogenic nosocomial strains Remove foreign material (e.g. lines) as quickly as possible; reduce risk of line associated infection

    21. Ubiquitous skin distribution; normal flora Multi-resistant to wide range of antibiotics Most common cause of infections associated with indwelling devices Biofilm: key virulence factor? behaves like a multicellular organism - antibiotics ineffective against biofilm orgs - sheds organisms that seed other sites To cure infection? must remove device Unique Aspects of Pathogenesis:

    22. Summary: S.epidermidis: skin is reservoir (i.e endogenous) Opportunistic pathogen; Most common cause of device associated infections - traumatic bypassing of skin - indwelling device colonization? biofilm - shedding from device to spread systemically QS systems (agr, luxS); two-component response regulator systems control ? communication to form and maintain biofilm MSCRAMMs; exopolysaccharides & surface proteins - facilitate initiation and maturation of biofilm formed of both protein (SdrF etc) and polysaccharide (PNAG, PGA)

    23. References: Otto M Staphylococcus epidermidis – the “accidental” pathogen. Nature Reviews Microbiology 2009;7:555-567 Mack D, AP Davies, LG Harris, et al Microbial interactions in Staphylococcus epidermidis biofilms Anal Bioanal Chem 2007;387:399-408 McCann MT, BF Gilmore, SP Gorman Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm Pharmocol 2008;60:1551-1571 Anselmino M, M Vinci, C Comoglio et al Bacteriology of infected extracted pacemaker and ICD leads J Cardiovasc Med 2009;10:693-698 Uckay I, D Pittet, P Vaudaux et al Foreign body infections due to Staphylococcus epidermidis Annals of Med 2009;41:109-119 Arrecubieta C, M0H Lee, A Macey et al SdrF, a Staphylococcus epidermidis surface protein, binds Type I collagen. J Biol Chem 2007;282:18767-19776. Manual of Clinical Microbiology 9th Edition, P Murray, E Baron, J Jorgensen, M Landry, M Pfaller Editors, ASM publisher. Soderquist B, M Andersson, M Nilsson et al Staphylococcus epidermidis surface protei I (SesI) a marker of invasive capacity of S.epidermidis? J Med Microbiol Papers 2009 (doi:10.1099/jmm.0.008771-0) Cargil JS, M Upton Low concentrations of vancomycin stimulates biofilm formation in some clinical isolates of Staphylococcus epidermidis. Vadyvaloo V, Otto M Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medial devices. Int J Artif Organs 2005;28:1069-1078. Visai L, Arciolo CR, Pietrocola G et al Staphylococcus biofilm components as targets of vaccines and drugs. Int J Artif Organs 2007;9:813-819 Jarlov JO Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility. APMIS suppl 1999;91:1-42. Speziale P, Visai L, Rindi S et al Prevention and treatment of Staphylococcus biofilms. Curr Med Chem 2008;30:3185-3195.

More Related